In an experimental retinochoroidal inflammation in rabbits, topical Bromfenac was showed to penetrate into retinochoroidal tissue in concentrations high enough to target COX2 and inhibit its effect on blood-retinal barrier [66]. The gene discussed is PTGS2; the disease is inflammation.